PHASTAR
Phastar is a global specialist biometrics contract research organization offering statistical consulting, programming, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal quality, inspired by 4,000 years accumulated technical experience across the company. Phastar is headquartered in London (UK) and North Carolina (US) and has 16 offices across five continents.
Locations
- Africa
- APAC
- Australia
- Europe
- North America
Therapeutic Areas
- Bone / Osteoporosis
- Cardiovascular
- Central Nervous System
- Dental and Oral Health
- Dermatology
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Hepatology
- Immunology
- Infectious Diseases
- Inflammation
- Internal Diseases
- Metabolic Diseases
- Musculoskeletal
- Nephrology
- Neurology
- Nutrition and Health
- Obstetrics / Gynecology
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology/ENT (Ear/Nose/Throat)
- Pediatrics / Neonatology
- Pharmacology / Toxicology
- Podiatry
- Psychiatry
- Pulmonary
- Respiratory
- Rheumatology
- Sleep
- Surgery
- Thrombosis
- Urology
- Vaccines
Phastar implements standardized internal processes for all its services. It rigorously checks all data sets and outputs internally and independently at multiple stages during development, ensuring that 100% of its projects are delivered on time, error-free, and to the highest standard.
We closely collaborate with customers, regularly implementing their feedback to deliver best-in-class customer service at the cutting edge of innovation.
Phastar leverages the Medidata Partner Program and holds accreditation in several Medidata solutions, including Rave EDC (electronic data capture), ePRO (electronic patient-reported outcomes), a component of Medidata eCOA (electronic clinical outcome assessments), and RTSM (randomization and trial supply management system).